Skip to search formSkip to main contentSkip to account menu

Trileptal

Known as: Novartis brand of oxcarbazepine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

oxcarbazepine
oxcarbazepine 300 MG Oral Tablet [Trileptal]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Сравнительная эффективность и переносимость топирамата, вальпроатов и карбамазепина в монотерапии эпилепсии у детей и молодых взрослых
2008
2008
[Comparison of efficacy of trileptal (oxcarbazepine) and carbamazepine in the treatment of temporal epilepsy].
An aim of the study was to compare the spectrum of effects of oxcarbazepine and carbamazepine in patients with partial temporal… 
2008
2008
The use of the antiepileptic drug trileptal in the clinical practice
The data on therapeutical efficacy of the new antiepileptic drug trileptal (oxcarbazepine) and results of the own observations of… 
2006
2006
A pharmacoeconomic comparison of monotherapy with Tegretol, Finlepsin and Trileptal (preliminary data).
AIM Pharmacoeconomics comprises a system of relatively new methods that inform policy makers about the costs and benefits of… 
Review
2003
Review
2003
[New epileptic treatments. Current modalities and their utilization].
  • P. Thomas
  • Presse medicale
  • 2003
  • Corpus ID: 23155026
NINE NEW MOLECULES: Since 1990, nine antiepileptic drugs have been launched in France: vigabatrin (Sabril), felbamate (Taloxa… 
Review
2002
Review
2002
Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
2001
2001
Change in oxcarbazepine (Trileptal) formulation is associated with more side effects and higher blood concentrations.
2000
2000
Oxcarbazepin (Trileptal®): Ein neues Antiepileptikum zur Mono- und Kombinationstherapie
Mit Oxcarbazepin (OXC, Trileptal®) steht in Deutschland jetzt em weiteres neues Antiepileptikum zur Monound Kombinationstherapie… 
2000
2000
Oxcarbazepin (Trileptal®) Ein wirksames und gut verträgliches neues Medikament der ersten Wahl zur Behandlung fokaler Anfälle
ZusammenfassungOxcarbazepin (10,11-dihydro-10-oxo-5H-dibenz-[b,f]azepin-5-carboxamid; OXC, Handelsname Trileptal®) ist ein neues… 
Review
2000
Review
2000
[Oxcarbazepine (Trileptal). An effective and well tolerated new drug as first choice in treatment of focal seizures].
Oxcarbazepin (OXC; 10,11-dihydro-10-oxo-5H-dibenz-[b,f]azepin-5-carboxamid, trade name Trileptal) is a new antiepileptic drug for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)